An Eye on Volatility: Bristol-Myers Squibb Company (NYSE:BMY)

Key Statistics

Bristol-Myers Squibb Company (NYSE:BMY) escalated 0.44% and closed its last trading session at $46.09. Its opening price on the last trading day was $45.89. The company’s market cap is $75.3 Billion. The company has 1.63 Billion shares outstanding and 1.63 Billion shares were floated in market. The short ratio in the company’s stock is documented at 3.55 and the short float is around of 4.03%. Bristol-Myers Squibb Company has been given an analysts’ mean target of 57.8.

52-week High/Low

The highest price BMY stock touched in the last 12 month was $63.69 and the lowest price it hit in the same period was $44.3. Stock’s distance from 52 week High is -27.63% and the distance from 52 week Low is 4.04%.

Share Volume Analysis

A total of 19.85 Billion shares exchanged at hands and its average trading volume is standing at 18.53 Million shares. The relative volume of the stock is 1.07.

Stock Performance

Bristol-Myers Squibb Company (NYSE:BMY) performance during the last one year degraded -23.41 percent, while its year to date (YTD) performance showed a negative trend of -11.33 percent. The stock fell -27.11 percent over the past six months. The stock’s quarterly performance indicates a negative momentum of -3.42 percent, whereas its last one month trend is pessimistic with -9.57 percent. Its weekly performance showed downward trend of -1.24 percent.

Profit Margins Analysis

Profitability analysis helps a great deal in making investment decision. Net profit margin of the company was recorded at 21.8 percent, operating profit margin was 28.3 percent, while gross profit margin stands at 71.5 percent.

Key Ratios Review

Liquidity ratios help investors to determine a company’s ability to pay off its debts. For the most recent quarter, quick ratio was 1.5, current ratio was 1.6, LT Debt/Equity ratio was 0.4 and Total Debt/Equity ratio stands at 0.52, while Payout ratio is 0.531.

Return on Assets, Investment and Equity

Bristol-Myers Squibb Company (NYSE:BMY) has a Return on Assets of 14.6 percent, Return on Investment of 25.4 percent and a Return on Equity of 37.3 percent.

Simple Moving Average

Moving averages are used as a strong indicator for technical stock analysis and it helps investors in figuring out where the stock has been and also helps in determining where it may be possibly heading. Now we look at the Moving Averages, the 200-day is -14.72%, the 50-day is -7.33% and the 20-day is -3.74%.

EPS Growth Analysis

The company’s diluted EPS for trailing twelve months was 3.04.
EPS Estimate for the next year is 4.43.
EPS Estimate for the next Quarter is 1.08.
EPS Growth this year is 28.7 percent.

Earnings and Sales Growth

EPS growth for the next 5 years is 7.99 percent.
Annual EPS growth Past 5 years is 14.5 percent.
Annual Sales Growth in the past 5 years was 6.6 percent.
Quarterly Revenue Growth on year-over-year basis stands at 9.6 percent.
Quarterly Earnings Growth on year-over-year basis stands at 105.3 percent.

Investment Valuation Ratios

The company P/E (price to earnings) ratio is 15.17 and Forward P/E ratio is 10.4. The company P/S (price to Sales) ratio is 3.34, P/B (price to Book) ratio is 5.37, while its P/C (price to Cash) ratio stands at 8.48.

Volatility Analysis

If we look at the Volatility of Bristol-Myers Squibb Company (NYSE:BMY), Week Volatility is 1.42%, whereas Month Volatility is at 1.96%.

Technical Indicators

Bristol-Myers Squibb Company (NYSE:BMY)’s RSI (Relative strength index) is at 32.51, its ATR (Average True Range) value is 0.95, while its Beta factor was calculated at 0.78.

Earnings Release Date

The company is estimated to report earnings on Apr 25 BMO.

Analysts Recommendation

Bristol-Myers Squibb Company (NYSE:BMY) has an Analysts’ Mean Recommendation of 2.3.

Insider Ownership and Transactions

Bristol-Myers Squibb Company’s insider ownership stands at 0.1 percent, while its insider transaction is 0 percent.

Institutional Ownership and Transactions

Institutional ownership refers to the ownership stake in a company that is held by large financial organizations, pension funds or endowments. Bristol-Myers Squibb Company’s institutional ownership is 75.5%, while its institutional transactions stand at 0.07%.